NeuProScan

NeuProScan is an AI platform designed for the early detection of pre-clinical Alzheimer's from MRI scans. It utilizes AI technology to predict the likelihood of developing Alzheimer's years in advance, helping doctors improve diagnosis accuracy and optimize the use of costly PET scans. The platform is fully customizable, user-friendly, and can be run on devices or in the cloud. NeuProScan aims to provide patients and healthcare systems with valuable insights for better planning and decision-making.

Viz.ai is a leading provider of AI-powered care coordination solutions for healthcare providers. Its comprehensive platform leverages advanced algorithms to analyze medical imaging data, providing real-time insights and automated assessments to accelerate diagnosis and treatment. Viz.ai's solutions cover a wide range of therapeutic areas, including neurology, cardiology, vascular medicine, trauma, and radiology. The company's mission is to improve patient outcomes by closing the gaps between patients, clinicians, and life-saving treatments.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus's innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, a tool to identify and close gaps in care; LENS, a platform to find, access, and analyze multimodal real-world data; and ALGOS, algorithmic models connected to Tempus's assays to provide additional insight.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus' innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, which identifies and closes gaps in care; LENS, which finds, accesses, and analyzes multimodal real-world data; and ALGOS, algorithmic models connected to Tempus' assays to provide additional insight.

Viz.ai is an AI-powered care coordination platform that helps providers improve patient outcomes. The platform uses advanced algorithms to analyze medical imaging data and provide real-time insights and automated assessments to accelerate diagnosis and treatment. Viz.ai's solutions are used by hospitals and health systems across the country to improve care for patients with a variety of conditions, including stroke, heart disease, and cancer.

Beacon Biosignals provides an EEG neurobiomarker platform that is designed to accelerate clinical trials and enable new treatments for patients with neurological and psychiatric diseases. Their platform is powered by machine learning and a world-class clinico-EEG database, which allows them to analyze existing EEG data for insights into mechanisms, PK/PD, and patient stratification. This information can be used to guide further development efforts, optimize clinical trials, and enhance understanding of treatment efficacy.

Leny.ai is an AI-powered medical assistant designed to provide instant support to medical professionals and patients. It offers features such as differential diagnosis, treatment plan drafting, discharge instructions, referral letters, and lab value analysis. Leny.ai aims to streamline healthcare processes, save time, and provide reliable and accurate medical information. The platform is still in beta mode and continuously improving to offer more accurate responses. It is focused on data security and privacy, although not currently HIPAA compliant. Leny.ai is free of charge at present and plans to transition to a subscription-based model in the future.

The Unlearn Platform is an AI-powered tool designed to streamline clinical trials by creating digital twins of patients using clinical trial data. It offers unparalleled precision in predicting clinical outcomes at future time points, ultimately minimizing trial failure, reducing costs, and accelerating approval processes. The platform enhances trial efficiency, insights, and impact, tailored to the specific needs of each study.

Cleerly is a digital healthcare company transforming the way clinicians approach the treatment of heart disease. Our clinically-proven, AI-based digital care platform works with coronary computed tomography angiography (CCTA) imaging to help clinicians precisely identify and define atherosclerosis earlier, so they can provide personalized, life-saving treatment plans for all patients throughout their care continuum. We measure atherosclerosis - plaque build-up in the heart's arteries - not indirect markers such as risk factors and symptoms of disease. Our AI-enabled digital care pathway offers simpler, faster, more accurate heart disease evaluation and reporting that's tailored to each stakeholder, improving overall clinical and financial outcomes.

Linus Health is a next-generation digital cognitive assessment platform that enables earlier detection and intervention in brain health. It brings the power of AI to long-trusted cognitive tests, delivering rich insights and actionable clinical guidance. Linus Health's technology has been validated in over 20 published studies and is used by leading organizations to transform their approach to brain health.

RejuveAI is a decentralized token-based system that aims to democratize longevity globally. The Longevity App allows users to monitor essential health metrics, enhance lifespan, and earn RJV tokens. The application leverages revolutionary AI technology to analyze human body functions in-depth, providing insights for aging combat. RejuveAI collaborates with researchers, clinics, and data enthusiasts to ensure innovative outcomes are affordable and accessible. The platform also offers exclusive discounts on travel, supplements, medical tests, and longevity therapies.

meiua is an advanced technological solution designed specifically for healthcare professionals. Powered by cutting-edge artificial intelligence, it optimizes the drafting of medical records, freeing up time spent with patients. The platform listens, learns, and writes all your medical documentation, ensuring precise and effortless documentation. meiua offers features such as automatic recording of exchanges between you and your patients, customization of note templates, and generation of personalized summaries in less than a minute. It prioritizes data security and responsible AI use, aiming to enhance healthcare efficiency and provide personalized attention to each patient.

Suki Assistant is an enterprise-grade AI assistant designed to help clinicians save time and focus on patient care. It offers ambient documentation, dictation, ICD-10 and HCC coding, and question answering in one solution. Suki has deep integrations with major EHR systems, ensuring seamless data flow and clinician-reviewed content. The AI is designed to minimize risks of bias and hallucinations, with SOC2 Type 2 and HIPAA compliance. Suki serves large health systems, providing hassle-free partnerships and proven ROI within a short period. It offers advanced EHR integrations, bidirectional capabilities, and ultimate convenience for clinicians.

Sully.ai is the #1 all-in-one AI solution designed to save doctors' time by creating superhuman doctors. The platform offers a comprehensive set of features such as pre-visit screening, decision support, scribing, diagnosis assistance, clinical planning, and post-visit automations. Sully.ai is an automation platform that works seamlessly with Electronic Medical Records (EMR) systems, providing personalized and multilingual support for healthcare professionals. The AI model is HIPAA compliant and trained on real-life doctor encounters to enhance decision-making and streamline administrative tasks. With proven results in reducing repetitive tasks and improving efficiency, Sully.ai aims to transform healthcare delivery by empowering doctors to focus on patient care.

iCAD is an AI-powered application designed for cancer detection, specifically focusing on breast cancer. The platform offers a suite of solutions including Detection, Density Assessment, and Risk Evaluation, all backed by science, clinical evidence, and proven patient outcomes. iCAD's AI-powered solutions aim to expose the hiding place of cancer, providing certainty and peace of mind, ultimately improving patient outcomes and saving more lives.

Medlabreport.com is an AI-powered platform that helps users understand their medical exam results easily. By uploading a single file, users receive a comprehensive report within 5 minutes, focusing on personalized insights based on symptoms, age, and other factors. The platform's advanced AI analyzes symptoms, provides recommendations, and prioritizes focus areas, empowering users to take control of their health. While the reports are not a substitute for licensed medical diagnosis, they offer a fast second opinion and complementary perspective to traditional healthcare.

NeuProScan is an AI platform designed for the early detection of pre-clinical Alzheimer's from MRI scans. It utilizes AI technology to predict the likelihood of developing Alzheimer's years in advance, helping doctors improve diagnosis accuracy and optimize the use of costly PET scans. The platform is fully customizable, user-friendly, and can be run on devices or in the cloud. NeuProScan aims to provide patients and healthcare systems with valuable insights for better planning and decision-making.

The Unlearn Platform is an AI-powered tool designed to streamline clinical trials by creating digital twins of patients using clinical trial data. It offers unparalleled precision in predicting clinical outcomes at future time points, ultimately minimizing trial failure, reducing costs, and accelerating approval processes. The platform enhances trial efficiency, insights, and impact, tailored to the specific needs of each study.

DrugCard is an AI-enabled Data Intelligence platform designed to streamline drug safety routines by providing continuous and regular, traceable, transparent, accurate, complete, and scalable solutions for pharmacovigilance processes. The platform supports over 100 languages, monitors 1000+ local journals, and saves up to 70% of time compared to manual approaches. DrugCard caters to CROs, MAHs, and freelancers, offering efficient local literature screening services to ensure compliance with regulatory requirements and enhance productivity.

RejuveAI is a decentralized token-based system that aims to democratize longevity globally. The Longevity App allows users to monitor essential health metrics, enhance lifespan, and earn RJV tokens. The application leverages revolutionary AI technology to analyze human body functions in-depth, providing insights for aging combat. RejuveAI collaborates with researchers, clinics, and data enthusiasts to ensure innovative outcomes are affordable and accessible. The platform also offers exclusive discounts on travel, supplements, medical tests, and longevity therapies.

NeuProScan is an AI platform designed for the early detection of pre-clinical Alzheimer's from MRI scans. It utilizes AI technology to predict the likelihood of developing Alzheimer's years in advance, helping doctors improve diagnosis accuracy and optimize the use of costly PET scans. The platform is fully customizable, user-friendly, and can be run on devices or in the cloud. NeuProScan aims to provide patients and healthcare systems with valuable insights for better planning and decision-making.

Insight is an AI-powered medical research tool that serves as a research assistant for generating scientific summaries, hypotheses, experimental designs, and target identification. It empowers scientists to navigate literature, formulate hypotheses, and design experiments by utilizing peer-reviewed databases to provide reliable outputs. With integrated features like NIH PubMed access, NIH Reporter insights, and MYGENE & MYVARIANT deep dives, Insight streamlines the research process and accelerates discoveries in the medical field.

Biofourmis is a healthcare technology company that provides a connected technology platform for care delivery and drug development. The platform enables healthcare systems and pharmaceutical companies to deliver care and conduct clinical trials remotely, and to collect and analyze data to improve patient outcomes. Biofourmis's solutions have been shown to improve clinical, operational, and economic outcomes, such as reducing 30-day readmissions by 70%, detecting deterioration 21 hours sooner, and reducing cost of care by up to 38%.

AiCure provides a patient-centric eClinical trial management platform that enhances drug development through improved medication adherence rates, more powerful analysis and prediction of treatment response using digital biomarkers, and reduced clinical tech burden. AiCure's solutions support traditional, decentralized, or hybrid trials and offer flexibility to meet the needs of various research designs.

CompliantChatGPT is a HIPAA-compliant platform that allows users to utilize OpenAI's GPT models for healthcare-related tasks while maintaining data privacy and security. It anonymizes protected health information (PHI) by replacing it with tokens, ensuring compliance with HIPAA regulations. The platform offers various modes tailored to specific healthcare needs, including bloodwork analysis, PHI anonymization, diagnosis assistance, and treatment planning. CompliantChatGPT streamlines healthcare tasks, enhances productivity, and provides user-friendly assistance through its intuitive interface.

Freenome is a healthcare company that uses artificial intelligence and multiomics technology to detect cancer in its earliest stages through a simple blood draw. The company's mission is to make early cancer detection more accessible and affordable, and to improve the chances of successful treatment.

Nucleai is an AI-driven spatial biomarker analysis tool that leverages military intelligence-grade geospatial AI methods to analyze complex cellular interactions in a patient's biopsy. The platform offers a first-of-its-kind multimodal solution by ingesting images from various modalities and delivering actionable insights to optimize biomarker scoring, predict response to therapy, and revolutionize disease diagnosis and treatment.

Mendel AI is an advanced clinical AI tool that deciphers clinical data with clinician-like logic. It offers a fully integrated suite of clinical-specific data processing products, combining OCR, de-identification, and clinical reasoning to interpret medical records. Users can ask questions in plain English and receive accurate answers from health records in seconds. Mendel's technology goes beyond traditional AI by understanding patient-level data and ensuring consistency and explainability of results in healthcare.

neurons.bio is an AI application that offers a unique collection of over 100 AI agents designed for drug development, medicine, and life science research. These agents perform specific tasks efficiently, retrieve data from various sources, and provide insights to accelerate research processes. The platform aims to revolutionize drug discovery and development by integrating cutting-edge LLM technology with domain-specific agents, reducing research costs and time to clinic.

IXICO is a precision analytics company specializing in intelligent insights in neuroscience. They offer a range of services for drug development analytics, imaging operations, and post-marketing consultancy. With a focus on technology and innovation, IXICO provides expertise in imaging biomarkers, radiological reads, volumetric MRI, PET & SPECT, and advanced MRI. Their TrialTracker platform and Assessa tool utilize innovation and AI for disease modeling and analysis. IXICO supports biopharmaceutical companies in CNS clinical research with cutting-edge neuroimaging techniques and AI technology.

Ignota Labs is a technology company focused on rescuing failing drugs and bringing new life to abandoned projects, ultimately providing hope to patients. The company utilizes a proprietary AI model, SAFEPATH, which applies deep learning to bioinformatics and cheminformatics datasets to solve drug safety issues. Ignota Labs aims to identify promising drug targets, address safety problems in clinical trials, and accelerate the delivery of therapeutically effective drugs to patients.

Vizly is an AI-powered data analysis tool that empowers users to make the most of their data. It allows users to chat with their data, visualize insights, and perform complex analysis. Vizly supports various file formats like CSV, Excel, and JSON, making it versatile for different data sources. The tool is free to use for up to 10 messages per month and offers a student discount of 50%. Vizly is suitable for individuals, students, academics, and organizations looking to gain actionable insights from their data.

Image Bear AI is an advanced image recognition tool that utilizes artificial intelligence to analyze and identify objects within images. The application is designed to assist users in various industries such as e-commerce, security, and healthcare by providing accurate and efficient image analysis capabilities. With its cutting-edge technology, Image Bear AI offers a user-friendly interface and fast processing speeds, making it a valuable tool for businesses looking to streamline their image recognition processes.

OpenAI01.net is an AI tool that offers free usage with some limitations. It provides a new series of AI models designed to spend more time thinking before responding, capable of reasoning through complex tasks and solving harder problems in science, coding, and math. Users can ask questions and get answers for free, with the option to select different models based on credits. The tool excels in complex reasoning tasks and has shown impressive performance in various benchmarks.

Reimagine AI is an AI creative studio that specializes in building unique AI experiences bridging the gap between AI and human experiences. They offer immersive multimedia experiences like Lucy AI, MEMRY, and virtual companions for healthcare. The studio collaborates with various organizations to create AI-powered solutions and virtual beings for different purposes. Reimagine AI aims to spark imagination and dreams about the future through their innovative AI technologies.

Medlabreport.com is an AI-powered platform that helps users understand their medical exam results easily. By uploading a single file, users receive a comprehensive report within 5 minutes, focusing on personalized insights based on symptoms, age, and other factors. The platform's advanced AI analyzes symptoms, provides recommendations, and prioritizes focus areas, empowering users to take control of their health. While the reports are not a substitute for licensed medical diagnosis, they offer a fast second opinion and complementary perspective to traditional healthcare.

Viz.ai is an AI-powered care coordination platform that helps providers improve patient outcomes. The platform uses advanced algorithms to analyze medical imaging data and provide real-time insights and automated assessments to accelerate diagnosis and treatment. Viz.ai's solutions are used by hospitals and health systems across the country to improve care for patients with a variety of conditions, including stroke, heart disease, and cancer.

Beacon Biosignals provides an EEG neurobiomarker platform that is designed to accelerate clinical trials and enable new treatments for patients with neurological and psychiatric diseases. Their platform is powered by machine learning and a world-class clinico-EEG database, which allows them to analyze existing EEG data for insights into mechanisms, PK/PD, and patient stratification. This information can be used to guide further development efforts, optimize clinical trials, and enhance understanding of treatment efficacy.

Linus Health is a next-generation digital cognitive assessment platform that enables earlier detection and intervention in brain health. It brings the power of AI to long-trusted cognitive tests, delivering rich insights and actionable clinical guidance. Linus Health's technology has been validated in over 20 published studies and is used by leading organizations to transform their approach to brain health.

Viz.ai is a leading provider of AI-powered care coordination solutions for healthcare providers. Its comprehensive platform leverages advanced algorithms to analyze medical imaging data, providing real-time insights and automated assessments to accelerate diagnosis and treatment. Viz.ai's solutions cover a wide range of therapeutic areas, including neurology, cardiology, vascular medicine, trauma, and radiology. The company's mission is to improve patient outcomes by closing the gaps between patients, clinicians, and life-saving treatments.

Modality.AI is an AI application that has developed an automated, clinically validated system to assess neurological and psychiatric states both in clinic and remotely. The platform utilizes conversational AI to monitor conditions accurately and consistently, allowing researchers and clinicians to review data in near real-time and monitor treatment response over time. Modality.AI collaborates with world-class AI/Machine Learning experts and leading institutions to provide a HIPAA-compliant system for assessing various indications such as ALS, Parkinson's, depression, autism, Huntington's Disease, schizophrenia, and mild cognitive impairment. The platform enables convenient monitoring at home through streaming and analysis of speech and facial responses, without the need for special software or apps. Modality.AI is accessible on various devices with a browser, webcam, and microphone, offering a new approach to efficient and cost-effective clinical trials.